1.Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease

Weng, SF, Akyea, RK,     More...

Weng, SF, Akyea, RK, Man, KKC, Lau, WCY, Iyen, B, Blais, JE, Chan, EW, Siu, CW, Qureshi, N, Wong, ICK, Kai, J     Less

PLOS ONE[1932-6203], Published 2021, Volume 16, Issue 12,

收錄情况： WOS SCOPUS

WOS核心合集引用: 4  2023影響因子:  2.9  发表年影響因子:  3.752 

2.Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials

Blais, JE, Tong, GKY     More...

Blais, JE, Tong, GKY, Pathadka, S, Mok, M, Wong, ICK, Chan, EW     Less

PLOS ONE[1932-6203], Published 2021, Volume 16, Issue 2,

收錄情况： WOS SCOPUS

WOS核心合集引用: 8  2023影響因子:  2.9  发表年影響因子:  3.752 

3.Cardiovascular sequalae in uncomplicated COVID-19 survivors

Zhou, M, Wong, CK, U     More...

Zhou, M, Wong, CK, Un, KC, Lau, YM, Lee, JCY, Tam, FCC, Lau, YM, Lai, WH, Tam, AR, Lam, YY, Pang, P, Tong, T, Tang, M, Tse, HF, Ho, D, Ng, MY, Chan, EW, Wong, ICK, Lau, CP, Hung, IFN, Siu, CW     Less

PLOS ONE[1932-6203], Published 2021, Volume 16, Issue 2,

收錄情况： WOS SCOPUS

WOS核心合集引用: 39  2023影響因子:  2.9  发表年影響因子:  3.752 

4.Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study

Naser, AY, Wong, ICK     More...

Naser, AY, Wong, ICK, Whittlesea, C, Alwafi, H, Abuirmeileh, A, Alsairafi, ZK, Turkistani, FM, Bokhari, NS, Beykloo, MY, Al-Taweel, D, Almane, MB, Wei, L     Less

PLOS ONE[1932-6203], Published 2019, Volume 14, Issue 10,

收錄情况： WOS SCOPUS

WOS核心合集引用: 16  2023影響因子:  2.9  发表年影響因子:  2.740 

5.Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis

Ma, TT, Wong, ICK, M     More...

Ma, TT, Wong, ICK, Man, KKC, Chen, Y, Crake, T, Ozkor, MA, Ding, LQ, Wang, ZX, Zhang, L, Wei, L     Less

PLOS ONE[1932-6203], Published 2019, Volume 14, Issue 1,

收錄情况： WOS SCOPUS

WOS核心合集引用: 24  2023影響因子:  2.9  发表年影響因子:  2.740 

6.Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study

Kubota, K, Kamijima,     More...

Kubota, K, Kamijima, Y, Yang, YHK, Kimura, S, Lai, ECC, Man, KKC, Ryan, P, Schuemie, M, Stang, P, Su, CC, Wong, ICK, Zhang, YH, Setoguchi, S     Less

PLOS ONE[1932-6203], Published 2018, Volume 13, Issue 12,

收錄情况： WOS SCOPUS

WOS核心合集引用: 11  2023影響因子:  2.9  发表年影響因子:  2.776 

7.Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses

Li, X, Tse, VC, Lau,     More...

Li, X, Tse, VC, Lau, WCY, Cheung, BMY, Lip, GYH, Wong, ICK, Chan, EW     Less

PLOS ONE[1932-6203], Published 2016, Volume 11, Issue 6,

收錄情况： WOS SCOPUS

WOS核心合集引用: 9  2023影響因子:  2.9  发表年影響因子:  2.806 

8.Use of the SAMe-TT₂R₂ Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence

Chan, PH, Hai, JJ, C     More...

Chan, PH, Hai, JJ, Chan, EW, Li, WH, Tse, HF, Wong, ICK, Lip, GYH, Siu, CW     Less

PLOS ONE[1932-6203], Published 2016, Volume 11, Issue 3,

收錄情况： WOS SCOPUS

WOS核心合集引用: 36  2023影響因子:  2.9  发表年影響因子:  2.806 

9.Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project

de Bie, S, Ferrajolo     More...

de Bie, S, Ferrajolo, C, Straus, SMJM, Verhamme, KMC, Bonhoeffer, J, Wong, ICK, Sturkenboom, MCJM     Less

PLOS ONE[1932-6203], Published 2015, Volume 10, Issue 6,

收錄情况： WOS SCOPUS

WOS核心合集引用: 25  2023影響因子:  2.9  发表年影響因子:  3.057 

10.Adverse Drug Reactions in Hospitalised Children in Germany Are Decreasing: Results of a Nine Year Cohort-Based Comparison

Oehme, AK, Rashed, A     More...

Oehme, AK, Rashed, AN, Hefele, B, Wong, ICK, Rascher, W, Neubert, A     Less

PLOS ONE[1932-6203], Published 2012, Volume 7, Issue 9,

收錄情况： WOS SCOPUS

WOS核心合集引用: 13  2023影響因子:  2.9  发表年影響因子:  3.730